BESSEMER GROUP INC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 107 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,0000.0%2510.0%0.00%
Q4 2021$3,0000.0%2510.0%0.00%
Q3 2021$3,000
-40.0%
2510.0%0.00%
Q2 2021$5,0000.0%2510.0%0.00%
Q1 2021$5,000
-99.7%
251
-99.7%
0.00%
-100.0%
Q2 2020$1,926,000
+217.3%
86,359
+116.7%
0.01%
+200.0%
Q1 2020$607,00039,8590.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders